Lyons Gary A

Lyons Gary A is listed in filings as Director at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX) and Neurocrine Biosciences Inc (NBIX). The current snapshot covers public activity from May 16, 2025 to May 29, 2026. Reported amounts are shown as $412.4K to $130.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.